U.S. Paper and Forestry Products Stock News

Krystal Biotech recently received marketing authorization from the UK Medicines and Healthcare products Regulatory Agency for VYJUVEK, a genetic therapy for dystrophic epidermolysis bullosa with COL7A1 mutations, making it the first approved genetic medicine for this condition in the UK and granting up to 12 years of orphan market exclusivity. The approval’s flexible at‑home or healthcare‑setting dosing, including administration by patients or caregivers, could materially influence treatment...

On May 12, 2026, PagSeguro Digital reported first‑quarter 2026 results showing revenue of R$5,006 million and net income of R$546 million, alongside the completion of a share repurchase program totaling 22,895,742 shares for US$165.77 million under its May 29, 2025 authorization. The combination of higher quarterly revenue and earnings per share, together with a sizeable completed buyback, highlights management’s focus on both business performance and capital returns. With first‑quarter...

Kaiser Aluminum (KALU) is back on screens after a sharp year-to-date run, with earnings estimates revised higher and the stock benefiting from tighter aluminum supply, shipping disruptions, and tariff driven price support across the sector. See our latest analysis for Kaiser Aluminum. The recent move has been powerful, with the share price up 45.86% year to date and a 147.11% total shareholder return over one year. This suggests momentum has been building as earnings expectations and sector...

In recent days, Albemarle has attracted heightened attention as analysts lifted earnings forecasts for the current quarter and full fiscal year, supported by positive fundamental trends and strong revisions to consensus estimates. This shift has coincided with a Zacks Rank #1 (Strong Buy) rating and insider share sales of about US$3.0 million over three months, offering a mixed but informative signal about expectations and caution around the company. Next, we’ll examine how these upgraded...

IDEAYA Biosciences recently outlined a busy 2026 for its oncology pipeline, highlighting positive Phase I/II data for darovasertib in first-line HLA-A2 negative metastatic uveal melanoma and plans for an FDA expedited review and NDA submission aimed at accelerated approval. Alongside these clinical and regulatory steps, the company is already investing in commercial infrastructure, including sales leadership hires and supply-chain preparation, signaling a move toward potential...

What Black Hills’ New Shelf Registration Means for Investors Black Hills (BKH) has filed an omnibus shelf registration covering debt securities, preferred stock, depositary shares, common stock, warrants, purchase contracts, and units, giving the utility broad flexibility to raise capital as needed. See our latest analysis for Black Hills. At a share price of $74.29, Black Hills has seen steady upward momentum, with share price returns of 6.66% year to date and a 1 year total shareholder...

Brookdale Senior Living recently presented at the Bank of America Global Healthcare Conference in Las Vegas and the RBC Capital Markets Global Healthcare Conference in New York, highlighting its latest operational and financial updates. These appearances, coupled with management’s emphasis on rising occupancy, operational improvements, and double-digit 2026 EBITDA growth guidance, have reinforced market attention on Brookdale’s evolving business trajectory and leadership execution. Now,...

Credit agreement amendment reframes funding picture for GATX (GATX) GATX (GATX) amended its five-year credit agreement, extending the facility’s termination date to May 21, 2031, while cutting borrowing margins and facility fees tied to the company’s public credit rating. See our latest analysis for GATX. The stock’s recent 30 day share price return is down 14.38% and the 90 day share price return is down 10.10%. However, the 1 year total shareholder return of 16.53% and 5 year total...

In May 2026, Damora Therapeutics, Inc. reported first-quarter results showing a net loss of US$27.78 million, compared with US$2.53 million a year earlier. This sharp widening of quarterly losses highlights how the company’s cost structure and spending profile are evolving at an early stage of its development. Next, we’ll examine how this much larger quarterly net loss shapes Damora Therapeutics’ investment narrative and future financial considerations. Capitalize on the AI infrastructure...

In its recently reported Q1 results, Stewart Information Services posted revenue growth of 27.7% year on year and exceeded both earnings and revenue expectations, with CEO Fred Eppinger highlighting strong momentum across the business. This broad-based outperformance against analyst forecasts suggests Stewart’s operational initiatives are gaining traction across key segments, potentially strengthening its longer-term growth thesis. Now, we’ll examine how this stronger-than-expected Q1...

Penske Automotive Group, Inc. recently announced that its Board approved a quarterly dividend of US$1.42 per share, a US$0.02 (about 1.4%) increase and the company’s 22nd consecutive quarterly raise, payable on June 3, 2026 to shareholders of record as of May 26, 2026. This long-running pattern of dividend growth underlines Penske Automotive Group’s ongoing emphasis on cash returns to shareholders and board confidence in the business’s financial position. We’ll now examine how Penske...

In May 2026, StoneCo Ltd. reported first-quarter 2026 results showing revenue of R$3,578.02 million and net income of R$1,706.53 million, with basic earnings per share from continuing operations of R$7.17. Alongside this earnings jump, StoneCo’s rapidly growing credit business and the Board’s approval of an extraordinary US$2.53 per-share cash dividend highlighted an intensifying focus on higher-margin financial services and capital returns. We’ll now examine how StoneCo’s sharp earnings...

For investors considering whether Delta Air Lines at around US$76.14 represents fair value or a potential opportunity, this article explains what the current price might be implying about the stock. The stock has recently posted returns of 12.4% over 7 days, 11.2% over 30 days, 10.3% year to date and 56.0% over the past year, with longer-term figures of 116.9% over 3 years and 65.0% over 5 years that many investors will want to frame against valuation. Recent headlines around Delta have...

California Resources (CRC) has reached first carbon dioxide injection at its Carbon TerraVault I project in Elk Hills Field, Kern County, creating California’s first operational carbon capture and storage hub for industrial emitters. See our latest analysis for California Resources. The first CO2 injection comes as the share price has eased 4.2% over the past month but is still up 33.7% year to date, with a 1 year total shareholder return of 50.1% suggesting momentum has been building over a...

In May 2026, KeyCorp announced a new share repurchase program of up to US$3.00 billion, following the completion of a prior US$720.00 million buyback, while also filing a US$498.00 million common stock shelf registration tied to its employee stock ownership plan and declaring second-quarter dividends on its common and preferred shares. This mix of large-scale repurchases, fresh issuance capacity for employee plans, and continued dividends highlights how KeyCorp is actively balancing capital...

Quanta Services (NYSE:PWR) has appointed Joseph Kim to its Board of Directors, adding operational and supply chain experience to its governance structure. The company has also approved a new share repurchase program authorizing up to $1b of stock buybacks. These actions reflect recent company decisions that have not been widely discussed and are likely to interest existing and potential shareholders. Quanta Services is making these moves with its stock trading at $723.44, following multi...

F&G Annuities & Life (FG) has just been added to the S&P SmallCap 600, S&P 1000, and S&P Composite 1500 indices. This change can influence trading activity as index-tracking funds adjust their portfolios. See our latest analysis for F&G Annuities & Life. That index inclusion comes after a mixed run, with the 90 day share price return of 19.17% contrasting with a year to date share price decline of 7.49% and a 1 year total shareholder return down 10.91%. The 3 year total shareholder return...

LexinFintech Holdings (NasdaqGS:LX) opened 2026 with Q1 revenue of C¥3.3b and basic EPS of C¥1.21, against a trailing twelve month EPS of C¥8.59 and net income of C¥1,448.19m that translated into a 10.8% net margin over the past year. The company reported quarterly revenue of C¥3.10b in Q1 2025 and C¥3.31b in Q1 2026, while basic EPS went from C¥2.55 to C¥1.21 over the same period. This frames the latest results in the context of a year of 9% earnings growth and an improved margin profile...

In May 2026, YETI Holdings reported first-quarter sales of US$380.41 million, up from US$351.13 million a year earlier, while net income fell to US$9.85 million from US$16.61 million and the company recorded US$973,000 of long-lived asset impairments. Alongside these results, YETI raised the lower end of its 2026 sales growth guidance to a 7%–8% range and expanded its share repurchase authorization to US$998.00 million, signaling confidence in demand for its core products and brand. Now,...

Colgate-Palmolive stock snapshot after recent performance Colgate-Palmolive (CL) has drawn investor attention after a 1-month return of 7.04%, alongside a 3-month decline of 6.27%. This combination is prompting closer inspection of how its fundamentals line up with recent price action. See our latest analysis for Colgate-Palmolive. At a share price of US$90.61, Colgate-Palmolive’s recent 7.04% 1-month share price return contrasts with a 6.27% decline over 3 months, while its 5-year total...

Recent performance context for Supernus Pharmaceuticals Without a single headline event driving attention today, Supernus Pharmaceuticals (SUPN) is on some investors’ radars after a mixed stretch. The stock is down about 3% over the past month and 14% over the past 3 months. See our latest analysis for Supernus Pharmaceuticals. At a share price of US$48.21, Supernus Pharmaceuticals has seen short term share price weakness, with the 90 day share price return down 14.4%, while the 1 year total...

If you are wondering whether Rexford Industrial Realty is currently priced fairly, this article helps you connect the recent share price with what the underlying business might be worth. The stock last closed at US$36.18, with returns of 3.3% over the past week, 2.0% over the past month, a decline of 7.3% year to date, a 7.1% gain over the past year, and declines of 25.8% and 23.9% over the past three and five years respectively. Recent headlines around Rexford Industrial Realty have focused...

Earlier this week, Murphy Oil came under pressure as reports of progress toward a U.S.–Iran peace resolution coincided with lower crude prices and a broad pullback in energy producers exposed to the Hormuz Strait risk premium. At the same time, concerns that Murphy Oil may be trading above estimates of its intrinsic value, alongside recent insider share sales, added a valuation-focused layer to investor caution around the company. We’ll now examine how the easing Hormuz-related risk premium...

Ferrari has revealed its first fully electric car, created in collaboration with former Apple designer Sir Jony Ive. The launch marks Ferrari's entry into the fully electric vehicle segment, signaling a new chapter for the company. The development highlights a stronger focus on design and technology as the auto industry continues to shift toward electric mobility. For investors watching NYSE:RACE, the move into fully electric vehicles comes as the stock trades around $348.24. Over the past...